Contract Research Organization XenoTech, LLC, a division of Sekisui, has announced plans to relocate into a new 41,500 ft2 facility. The planned move will double the size of XenoTech’s global ...
XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies WESTBURY, N.Y., Sept. 12, ...
10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assured. The combination of the already successful XenoTech and the vast and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sekisui XenoTech, a CRO based in Kansas City, Kan., helps ...
BALTIMORE, February 2 /PRNewswire/ — Celsis In Vitro, Inc. (Celsis IVT) announced today that it has filed apatent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd.,and Sekisui ...
No articles found. Sekisui XenoTech, LLC did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are wholly ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results